Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.
Huntington's disease (HD) is generally considered a prototypic motor disorder, but cognitive deficits are also prominent features of the disease. Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3NP) has been proposed to be a phenotypic model of HD in rats and nonhuman primates. In this study, we investigated the effect of 5 days continuous subcutaneous infusion of 3NP on motor and cognitive abilities in Lewis rats. Intoxicated animals developed a motor syndrome consisting of bradykinesia as well as gait abnormalities and dystonic hindlimbs. Results from learning tasks showed that these rats: (1) did not exhibit learning deficits per se in our discrimination task but showed impairments in inhibiting behavioral responses when a transfer of learning (to new stimuli) or a transfer of response (new position of the lever) was required; (2) showed a marked tendency to persevere in choosing the compartment they previously visited in a T maze, thus leading to a clear retardation in learning a reinforced alternation task; and (3) did not show any memory deficit when a delay was introduced. Six months later, histological analyses showed severe neurodegeneration within the lateral striatum accompanied by apparent cell loss in the ventral pallidum and entopedoncular nucleus. We suggest that the 3NP rat model of basal ganglia neurodegeneration may provide a useful model for studying certain fundamental aspects of the physiopathology of HD and for evaluating the functional efficacy of new therapeutic strategies.
El Massioui
N
N
Laboratoire de Neurobiologie de l'Apprentissage, de la Mémoire, et de la Communication, Unité Mixte de Recherche 8620, Centre National de la Recherche Scientifique, Bt 446, Université Paris-Sud, 91405 Orsay Cedex, France.
Ouary
S
S
Chéruel
F
F
Hantraye
P
P
Brouillet
E
E
D000818:Animals; D001288:Attention / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D003071:Cognition / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects / Q000473:pathology; D004193:Discrimination Learning / Q000187:drug effects; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D005917:Globus Pallidus / Q000187:drug effects / Q000473:pathology; D006816:Huntington Disease / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D007279:Injections, Subcutaneous; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009574:Nitro Compounds; D011422:Propionates / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D011917:Rats, Inbred Lew; D012718:Set, Psychology; D014163:Transfer, Psychology / Q000187:drug effects
D009574:Nitro Compounds; D011422:Propionates; C015392:3-nitropropionic acid